{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:36:13Z","timestamp":1780360573507,"version":"3.54.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1016\/j.ijrobp.2007.09.051","type":"journal-article","created":{"date-parts":[[2008,3,6]],"date-time":"2008-03-06T23:48:09Z","timestamp":1204847289000},"page":"213-219","source":"Crossref","is-referenced-by-count":125,"title":["Impact of [18F] Fluorodeoxyglucose Positron Emission Tomography on Staging and Management of Early-Stage Follicular Non-Hodgkin Lymphoma"],"prefix":"10.1016","volume":"71","author":[{"given":"Andrew","family":"Wirth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Foo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Seymour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"MacManus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodney J.","family":"Hicks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2007.09.051_bib1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/hon.743","article-title":"Radiation therapy for localized low-grade non-Hodgkin's lymphomas","volume":"23","author":"Tsang","year":"2005","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.ijrobp.2007.09.051_bib2","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1200\/JCO.1996.14.4.1282","article-title":"Is radiotherapy curative for Stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University","volume":"14","author":"Mac Manus","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2007.09.051_bib3","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.ijrobp.2005.08.010","article-title":"Long-term outcome and mortality trends in early-stage, Grade 1\u20132 follicular lymphoma treated with radiation therapy","volume":"64","author":"Guadagnolo","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2007.09.051_bib4","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/S0360-3016(01)01747-3","article-title":"Long-term results with radiotherapy for Stage I\u2013II follicular lymphomas","volume":"51","author":"Wilder","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2007.09.051_bib5","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0167-8140(95)01600-L","article-title":"Radiotherapy results in early stage low grade nodal non-Hodgkin's lymphoma","volume":"36","author":"Pendlebury","year":"1995","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2007.09.051_bib6","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/bjc.1994.213","article-title":"Clinical stage 1 non-Hodgkin's lymphoma: Long-term follow-up of patients treated by the British National Lymphoma Investigation with radiotherapy alone as initial therapy","volume":"69","author":"Vaughan Hudson","year":"1994","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ijrobp.2007.09.051_bib7","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1080\/02841860310014435","article-title":"A systematic overview of radiation therapy effects in non-Hodgkin's lymphoma","volume":"42","author":"Gustavsson","year":"2003","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ijrobp.2007.09.051_bib8","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1365-2141.2006.06284.x","article-title":"Positron emission tomography\/computed tomography: Diagnostic accuracy in lymphoma","volume":"135","author":"Hernandez-Maraver","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ijrobp.2007.09.051_bib9","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1053\/j.semnuclmed.2004.03.002","article-title":"Positron emission tomography in the evaluation of lymphoma","volume":"34","author":"Israel","year":"2004","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.ijrobp.2007.09.051_bib10","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1002\/cncr.21253","article-title":"A metaanalysis of 18F-2-deoxy-2-fluoro-D-glucose positron emission tomography in the staging and restaging of patients with lymphoma","volume":"104","author":"Isasi","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2007.09.051_bib11","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/MNM.0b013e3280895e34","article-title":"The role of FDG PET in the management of lymphoma: Practical guidelines","volume":"28","author":"Kirby","year":"2007","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.ijrobp.2007.09.051_bib12","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/MNM.0b013e3280895e23","article-title":"The role of FDG PET in the management of lymphoma: What is the evidence base?","volume":"28","author":"Kirby","year":"2007","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.ijrobp.2007.09.051_bib13","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1200\/JCO.1999.17.12.3835","article-title":"World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November 1997","volume":"17","author":"Harris","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2007.09.051_bib14","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1200\/JCO.1989.7.11.1630","article-title":"Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting","volume":"7","author":"Lister","year":"1989","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2007.09.051_bib15","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","article-title":"Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group","volume":"17","author":"Cheson","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2007.09.051_bib16","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","article-title":"Revised response criteria for malignant lymphoma","volume":"25","author":"Cheson","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2007.09.051_bib17","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1089\/108497801753131372","article-title":"Positron emission tomography (PET) for staging low-grade non-Hodgkin's lymphomas (NHL)","volume":"16","author":"Najjar","year":"2001","journal-title":"Cancer Biother Radiopharm"},{"key":"10.1016\/j.ijrobp.2007.09.051_bib18","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1182\/blood-2002-09-2778","article-title":"Utility of FDG-PET scanning in lymphoma by WHO classification","volume":"101","author":"Elstrom","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.ijrobp.2007.09.051_bib19","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1093\/annonc\/mdl014","article-title":"18F-fluoro-deoxy-glucose positron emission tomography (18F-FDG-PET) visualizes follicular lymphoma irrespective of grading","volume":"17","author":"Wohrer","year":"2006","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2007.09.051_bib20","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1023\/A:1011169332265","article-title":"Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of low-grade non-Hodgkin's lymphoma (NHL)","volume":"12","author":"Jerusalem","year":"2001","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2007.09.051_bib21","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3816\/CLM.2002.n.012","article-title":"Positron emission tomography in non-Hodgkin's lymphoma (NHL): relationship between tracer uptake and pathological findings, including preliminary experience in the staging of low-grade NHL","volume":"3","author":"Jerusalem","year":"2002","journal-title":"Clin Lymphoma"},{"key":"10.1016\/j.ijrobp.2007.09.051_bib22","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/cncr.21967","article-title":"Role of fluorine-18 fluoro-deoxyglucose positron emission tomography scan in the evaluation and follow-up of patients with low-grade lymphomas","volume":"107","author":"Karam","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2007.09.051_bib23","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3816\/CLM.2003.n.013","article-title":"Frequent impact of [18F]fluorodeoxyglucose positron emission tomography on the staging and management of patients with indolent non-Hodgkin's lymphoma","volume":"4","author":"Blum","year":"2003","journal-title":"Clin Lymphoma"},{"key":"10.1016\/j.ijrobp.2007.09.051_bib24","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1200\/JCO.1998.16.2.603","article-title":"18-F-fluorodeoxyglucose-positron emission tomography as a new approach to detect lymphomatous bone marrow","volume":"16","author":"Moog","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2007.09.051_bib25","doi-asserted-by":"crossref","unstructured":"Ribrag V, Vanel D, Leboulleux S, et al. Prospective study of bone marrow infiltration in aggressive lymphoma by three independent methods: Whole-body MRI, PET\/CT and bone marrow biopsy. Eur J Radiol 2007, July 23 [Epub ahead of print].","DOI":"10.1016\/j.ejrad.2007.06.014"},{"key":"10.1016\/j.ijrobp.2007.09.051_bib26","first-page":"958","article-title":"18F-FDG PET for evaluation of bone marrow infiltration in staging of lymphoma: A meta-analysis","volume":"46","author":"Pakos","year":"2005","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ijrobp.2007.09.051_bib27","doi-asserted-by":"crossref","first-page":"4643","DOI":"10.1200\/JCO.2005.12.072","article-title":"Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin's lymphoma","volume":"23","author":"Schoder","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2007.09.051_bib28","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/annonc\/mdj024","article-title":"Is CT scan still necessary for staging in Hodgkin and non-Hodgkin lymphoma patients in the PET\/CT era?","volume":"17","author":"Raanani","year":"2006","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2007.09.051_bib29","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.radonc.2004.07.029","article-title":"Addition of 18F-FDG-PET scans to radiotherapy planning of thoracic lymphoma","volume":"73","author":"Lee","year":"2004","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2007.09.051_bib30","first-page":"193","article-title":"PET imaging today: Contribution to the initial staging and prognosis of patients with non-Hodgkin's lymphomas","volume":"158","author":"Sattar","year":"2006","journal-title":"J La State Med Soc"},{"key":"10.1016\/j.ijrobp.2007.09.051_bib31","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1600-0609.2006.00802.x","article-title":"Clinical impact of FDG-PET\/CT in the planning of radiotherapy for early-stage Hodgkin lymphoma","volume":"78","author":"Hutchings","year":"2007","journal-title":"Eur J Haematol"},{"issue":"Suppl. 1","key":"10.1016\/j.ijrobp.2007.09.051_bib32","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1007\/s00259-003-1165-6","article-title":"PET for staging of Hodgkin's disease and non-Hodgkin's lymphoma","volume":"30","author":"Schiepers","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ijrobp.2007.09.051_bib33","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1200\/JCO.1999.17.7.2153","article-title":"Interobserver variability in the detection of cervical-thoracic Hodgkin's disease by computed tomography","volume":"17","author":"Fletcher","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2007.09.051_bib34","series-title":"Computed body tomography","first-page":"245","article-title":"8. Mediastinum","author":"Sagel","year":"1989"},{"key":"10.1016\/j.ijrobp.2007.09.051_bib35","series-title":"Computed body tomography","first-page":"707","article-title":"Retroperitoneum","author":"Lee","year":"1989"},{"key":"10.1016\/j.ijrobp.2007.09.051_bib36","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1023\/A:1008332713631","article-title":"Response criteria for NHL: Importance of \u201cnormal\u201d lymph node size and correlations with response rates","volume":"11","author":"Grillo-Lopez","year":"2000","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2007.09.051_bib37","first-page":"145","article-title":"18F-FDG imaging: pitfalls and artifacts","volume":"33","author":"Abouzied","year":"2005","journal-title":"J Nucl Med Technol"},{"key":"10.1016\/j.ijrobp.2007.09.051_bib38","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1097\/RLU.0b013e318126c01c","article-title":"Atypical brown fat distribution in young males demonstrated on PET\/CT","volume":"32","author":"Clarke","year":"2007","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.ijrobp.2007.09.051_bib39","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.2214\/AJR.06.0552","article-title":"Thymic extension in the superior mediastinum in patients with thymic hyperplasia: Potential cause of false-positive findings on 18F-FDG PET\/CT","volume":"188","author":"Smith","year":"2007","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.ijrobp.2007.09.051_bib40","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/cncr.22370","article-title":"How do oncologists deal with incidental abnormalities on whole-body fluorine-18 fluorodeoxyglucose PET\/CT?","volume":"109","author":"Wang","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2007.09.051_bib41","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1007\/s00330-005-0088-y","article-title":"False-positive FDG PET uptake\u2014the role of PET\/CT","volume":"16","author":"Rosenbaum","year":"2006","journal-title":"Eur Radiol"},{"key":"10.1016\/j.ijrobp.2007.09.051_bib42","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1200\/JCO.2003.07.111","article-title":"Long-term follow-up of a prospective study of combined modality therapy for stage I\u2013II indolent non-Hodgkin's lymphoma","volume":"21","author":"Seymour","year":"2003","journal-title":"J Clin Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301607043696?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301607043696?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T19:11:09Z","timestamp":1557342669000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301607043696"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S0360301607043696"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2007.09.051","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}